Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emergent BioSolutions is a specialty biopharmaceutical company that develops and manufactures life-saving medical countermeasures for public health threats. The company is best known for Narcan (naloxone) nasal spray, the leading treatment for opioid overdose reversal, and its extensive portfolio of vaccines and therapeutics for anthrax and smallpox. Emergent also provides contract development and manufacturing (CDMO) services to government and commercial clients, leveraging its expertise in complex biologics. Headquartered in Maryland, the company is a key partner to the U.S. government in maintaining the Strategic National Stockpile.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerging Business Solutions.